BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 35434126)

  • 1. Upregulation of Synuclein-
    Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
    Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
    J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma.
    Cheng JC; Chiang MT; Lee CH; Liu SY; Chiu KC; Chou YT; Huang RY; Huang SM; Shieh YS
    J Dent Res; 2016 Apr; 95(4):439-45. PubMed ID: 26661712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of synuclein-γ levels by novel monoclonal antibody in saliva and cancer tissues from oral squamous cell carcinoma patients.
    Wang K; Shen Y; Xu J; Li Z; Liu Y; Yu C; Peng L; Zheng J; Zeng Y
    Neoplasma; 2020 May; 67(3):707-713. PubMed ID: 32202903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2.
    Ma D; Chen J; Shi Y; Gao H; Wei Z; Fan J; Wang L
    Sci Rep; 2024 Apr; 14(1):9616. PubMed ID: 38671227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
    Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of RACK1 and EGP40 in oral squamous cell carcinoma and its correlation with clinicopathological features and prognosis].
    Duan YH; Wu KL; Mei J; Zhou YY; Liu MS
    Shanghai Kou Qiang Yi Xue; 2023 Aug; 32(4):385-390. PubMed ID: 38044732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse correlation between Naa10p and Pirh2 expression and the combined prognostic value in oral squamous cell carcinoma patients.
    Zheng J; Wang F; Yang Y; Xu J; Yang J; Wang K; Liu Y; Du G; Zeng Y
    J Oral Pathol Med; 2019 Sep; 48(8):686-695. PubMed ID: 31134698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
    Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of XRN2 acts as an oncogene in oral squamous cell carcinoma and correlates with poor prognosis.
    Liu JC; Gao L; Li SM; Zheng JJ; Li DG; Zhi KQ; Ren WH
    Pathol Res Pract; 2021 Mar; 219():153355. PubMed ID: 33626405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
    Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
    BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propofol facilitates migration and invasion of oral squamous cell carcinoma cells by upregulating SNAI1 expression.
    Li C; Xia M; Wang H; Li W; Peng J; Jiang H
    Life Sci; 2020 Jan; 241():117143. PubMed ID: 31811855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the correlation between combined detection of RACK1 and M2/M1 in oral squamous cell carcinoma and prognosis of the patients].
    Zhu J; Xu T; Song DH; Wu SB
    Shanghai Kou Qiang Yi Xue; 2022 Oct; 31(5):517-522. PubMed ID: 36758601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family with Sequence Similarity 72 (FAM72) - A prospective biomarker for poor prognosis in patients with oral squamous cell carcinoma.
    Liu H; Huang Y; Chen Y; Tang Z; Huang M; Ming Y; Wang M; Chen W; Huang Z; Qing L; Wang Q; Jia B
    Arch Oral Biol; 2023 Jul; 151():105695. PubMed ID: 37086493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6.
    Zhang C; Cai Q; Ke J
    Int Dent J; 2023 Apr; 73(2):178-185. PubMed ID: 35820930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of RKIP, TGM2, and CMTM4 expression in oral squamous cell carcinoma.
    Luo T; Xu T; Ou Y; Ci H; Sun J
    Medicine (Baltimore); 2024 Feb; 103(7):e37278. PubMed ID: 38363884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.